MS Patients Continue to Gain Function and Show Improvement With the International Society for Stem Cell Research’s Annual Meeting as his backdrop, Dr. Saud A. Sadiq delivered more promising results from Tisch MS Research Center of New York’s (Tisch MSRCNY) FDA-approved Phase I stem cell trial. The...
The Center will close today, Thursday, July 2nd at 5:00pm and will re-open on Monday, July 6th in observance of Independence Day. Wishing you all a very safe and happy July 4th holiday!
Chronogram , a monthly mid-Hudson Valley magazine covering events and ideas that nourish and support the creative life of the region, interviewed IMSMP patients Beth Broun and Liz Maslow Montesano. The interview followed the Tisch MS Research Center’s April announcement at the 2015 American Academy...
The Tisch MS Research Center will close at 2:00pm today and remain closed through Monday, May 25th. We wish everyone a safe, happy, and healthy holiday weekend.
Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis New York, NY - April 23, 2015 - Tisch MS Research Center of New York (Tisch MSRCNY) today announced encouraging preliminary results from its FDA-approved Phase I...
This week eight of Tisch MSRCNY’s researchers arrived in Washington, D.C. to attend the 67 th American Academy of Neurology Annual Meeting. Eight of the Center’s Abstracts will be presented at the meeting. Dr. Sadiq was also informed on Monday that the preliminary results from our FDA-approved...
We are currently the only center in the United States that is conducting an FDA approved clinical trial using stem cells in patients with MS. The goal of the Phase I trial is to determine whether or not the therapy is safe and effective. We hope that this will lead to additional future trials and...
Metabolomics is an emerging field of science that studies the collection of all metabolites in a biological system. Dr. Fozia Mir, Assistant Research Scientist at Tisch MS, presented a comprehensive overview of how metabolomic studies are currently being applied to MS research. Dr. Mir also...
Today, Dr. Saud A. Sadiq and Dr. Massimiliano Cristofanilli will present at a meeting held by the San Marino Foundation for the Research and Treatment of Autoimmune Diseases and the Sammarinese Association for Multiple Sclerosis in San Marino, organized by Dr. Susanna Guttmann, Chief Neurologist...
Two studies from the Tisch MS Center were selected by the American Academy of Neurology (AAN) Science Committee to be highlighted as a significant advance based on animal research. Congratulations to first authors Ruth-Anne Langan (Dr. Violaine Harris' group) and Dr. Marwan Alahiri (Dr. Ying Liu's...